Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease
- Substances:GolimumabGuselkumab
Portugal- Participants:18–64 years · 65+ years
- Substances:Golimumab
Rare diseases
Investigational molecules
Locations
PortugalStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
Portugal
PortugalLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
PortugalBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
PortugalOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
PortugalZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
PortugalLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
PortugalA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
PortugalA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
PortugalStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
PortugalA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
PortugalTell us about your condition – we search every trial in Europe and connect you with the right site.